Skip to main content
Behavioral Healthcare Executive
Abuse, PTSD & Trauma
Alzheimer’s Disease, Dementia & Cognitive Disorders
Child & Adolescent Psychiatry
Coping During COVID-19
Major Depressive Disorder
Psych Congress Year-Round
Schizophrenia & Psychotic Disorders
Your Questions Answered
CME Conference Calendar
Cocaine, Meth & Stimulant Summit
Elevate by Psych Congress
Evolution of Psychotherapy
National Conference on Addiction Disorders East
National Conference on Addiction Disorders West
Psych Congress Regionals
Rx Drug Abuse & Heroin Summit
Treatment Center Investment & Valuation Retreat
APA Key Clinical Topics
Psych Congress On-Demand
NCAD East On-Demand
Centers of Excellence
Advertising And Event Opportunities
Editorial Advisory Board
Classifieds & Jobs for Healthcare Professionals
Treatment Approaches for Patients With Depression and Substance Use Disorders
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
Detecting Mixed Features in Major Depression
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
Best Practices for Administering Esketamine
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Q&A With Phillip J. Resnick on School Shootings
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help…
Using Thyroid Hormone in Depression Treatment
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.
Stay in the know.
Psychiatry and Behavioral Health Learning Network Newsletter
Back to Top